microRNA-23a in Human Cancer: Its Roles, Mechanisms and Therapeutic Relevance
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
microRNA-23a (miR-23a) is one of the most extensively studied miRNAs in different types of human cancer, and plays various roles in the initiation, progression, and treatment of tumors. Here, we comprehensively summarize and discuss the recent findings about the role of miR-23a in cancer. The differential expression of tissue miR-23a was reported, potentially indicating cancer stages, angiogenesis, and metastasis. miR-23a in human biofluid, such as plasma and salivary fluid, may be a sensitive and specific marker for early diagnosis of cancer. Tissue and circulating miR-23a serves as a prognostic factor for cancer patient survival, as well as a predictive factor for response to anti-tumor treatment. The direct and indirect regulation of miR-23a on multiple gene expression and signaling transduction mediates carcinogenesis, tumor proliferation, survival, cell migration and invasion, as well as the response to anti-tumor treatment. Tumor cell-derived miR-23a regulates the microenvironment of human cancer through manipulating both immune function and tumor vascular development. Several transcriptional and epigenetic factors may contribute to the dysregulation of miR-23a in cancer. This evidence highlights the essential role of miR-23a in the application of cancer diagnosis, prognosis, and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124
Meng, F., Henson, R., Lang, M., Wehbe, H., Maheshwari, S., Mendell, J. T., Jiang, J., Schmittgen, T. D., & Patel, T. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.057 · Cited by 984
Circulating Exosomal microRNAs as Biomarkers of Colon Cancer
Ogata-Kawata, H., Izumiya, M., Kurioka, D., Honma, Y., Yamada, Y., Furuta, K., Gunji, T., Ohta, H., Okamoto, H., Sonoda, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092921 · Cited by 809 · cited 1×
“Significant down-regulation of exosomal miR-23a was found after tumor resection, indicating the potential of exosomal miR-23a for colon cancer detection [63].”
BackgroundYong, F. L., Law, C. W., & Wang, C. W. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-280 · Cited by 176 · cited 1×
“3% accuracy), demonstrating its ability as a classifier for colorectal cancer detection [62].”
BackgroundThe NF-κB member p65 controls glutamine metabolism through miR-23a
Rathore, M. G., Saumet, A., Rossi, J.-F., de Bettignies, C., Tempé, D., Lecellier, C.-H., & Villalba, M. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.05.011 · Cited by 129
Targeting tumour microenvironment by tyrosine kinase inhibitor
Tan, H.-Y., Wang, N., Lam, W., Guo, W., Feng, Y., & Cheng, Y.-C. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0800-6 · Cited by 107
Self-citationLi, B., Sun, M., Gao, F., Liu, W., Yang, Y., Liu, H., Cheng, Y., Liu, C., & Cai, J. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000356607 · Cited by 54 · cited 9×
“Up-regulation of the miR-23a-targeted E-cadherin, mediates the Fas-induced EMT in gastric cancer [83].”
BackgroundInfluentialKoshkin, P. A., Chistiakov, D. A., Nikitin, A. G., Konovalov, A. N., Potapov, A. A., Usachev, D. Y., Pitskhelauri, D. I., Kobyakov, G. L., Shishkina, L. V., & Chekhonin, V. P. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.01.001 · Cited by 32
Su, L., & Liu, M. (2018) · Oncology Letters · doi:10.3892/ol.2018.8669 · Cited by 27 · cited 3×
“Expression of miR-23a was positively correlated with the tumor differentiation degree, lymph node metastasis, and clinical stages in ovarian cancer [51].”
BackgroundMicroRNA‑23a/27a/24‑2 cluster promotes gastric cancer cell proliferation synergistically
Hua, K., Chen, Y., Chen, C., Tang, Y., Huang, T., Lin, Y., Yeh, T., Huang, K., Lee, H., Hsu, M., et al. (2018) · Oncology Letters · doi:10.3892/ol.2018.8924 · Cited by 27
Cited by
The role of HPV gene expression and selected cellular MiRNAs in lung cancer development
Hussen, B. M., Ahmadi, G., Marzban, H., Fard Azar, M. E., Sorayyayi, S., Karampour, R., Nahand, J. S., Hidayat, H. J., & Moghoofei, M. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104692 · Cited by 62
The miR-23–27–24 cluster: an emerging target in NAFLD pathogenesis
Ru, L., Wang, X.-M., & Niu, J.-Q. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00819-w · Cited by 21
Chen, Y.-C., Lee, C. P., Hsiao, C.-C., Hsu, P.-Y., Wang, T.-Y., Wu, C.-C., Chao, T.-Y., Leung, S.-Y., Chang, Y.-P., & Lin, M.-C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228587 · Cited by 21
Liao, K., Niu, F., Hu, G., & Buch, S. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.984375 · Cited by 16
Lombari, P., Mallardo, M., Petrazzuolo, O., Amruthraj Nagoth, J., Fiume, G., Scanni, R., Iervolino, A., Damiano, S., Coppola, A., Borriello, M., et al. (2023) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfac232 · Cited by 4
Metadata
- Authors
- Wang, N., Tan, H.-Y., Feng, Y.-G., Zhang, C., Chen, F., & Feng, Y.
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2018-12-20
- Volume
- 11
- Issue
- 1
- Pages
- 7
- ISSN
- 2072-6694 (ISSN-L)
- OpenAlex
- W2903723297
- Cited by
- 99
- References
- 10
- FWCI
- 2.64
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: microRNA-23a in Human Cancer: Its Roles, Mechanisms and Therapeutic Relevance. https://app.cochat.ai/papers/10.3390/cancers11010007
- The paper
- Wang, N., Tan, H.-Y., Feng, Y.-G., Zhang, C., Chen, F., & Feng, Y. (2018). microRNA-23a in Human Cancer: Its Roles, Mechanisms and Therapeutic Relevance. Cancers. https://doi.org/10.3390/cancers11010007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.